猪繁殖与呼吸综合征(porcine reproductive and respiratory syndrome,PRRS)是世界上主要的猪传染性疾病之一,目前,疫苗和抗病毒药物只能提供有限的保护。本研究选择猪繁殖与呼吸综合征病毒(porcine reproductive and respiratory syndr...猪繁殖与呼吸综合征(porcine reproductive and respiratory syndrome,PRRS)是世界上主要的猪传染性疾病之一,目前,疫苗和抗病毒药物只能提供有限的保护。本研究选择猪繁殖与呼吸综合征病毒(porcine reproductive and respiratory syndrome virus,PRRSV)JXA1-R株ORF1a、ORF3、ORF4、ORF5、ORF6、ORF7的保守区域为靶序列,利用pSilencer2.1-U6neo构建shRNA表达载体并转染Marc-145细胞。经实时荧光定量PCR、细胞病变及病毒滴度分析,结果显示,ORF1a-4-shRNA、ORF3-1-shRNA、ORF6-2-shRNA干扰质粒能明显抑制病毒基因的转录,并有效抑制PRRSV在Marc-145上的增殖,显著降低病毒滴度。最后筛选ORF6-2-shRNA表达质粒转染猪胎儿成纤维细胞,构建稳定转染细胞株,为抗PRRSV转基因猪的生产奠定了基础。展开更多
Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ab...Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ability,the arginine-glycine-aspartic(RGD)peptide and the epidermal growth factor receptor interference(EGFRi)peptide were fused with MAP30,which was named ELRL-MAP30.The efficiency of targeted therapy for triple-negative breast cancer(TNBC)MDA-MB-231 cells,which lack the expression of estrogen receptor(ER),Progesterone receptor(PgR)and human epidermal growth factor receptor-2(HER2),is limited.In this study,we focus on exploring the effect and mechanism of ELRL-MAP30 on TNBC MDA-MB-231 cells.First,we discovered that ELRL-MAP30 significantly inhibited the migration and invasion of MDA-MB-231 cells and induced MDA-MB-231 cell apoptosis.Moreover,ELRL-MAP30 treatment resulted in a significant increase in Bax expression and a decrease in Bcl-2 expression.Furthermore,ELRL-MAP30 triggered apoptosis via the Fak/EGFR/Erk and Ilk/Akt signaling pathways.In addition,recombinant ELRL-MAP30 can inhibit chicken embryonic angiogenesis,and also inhibit the tube formation ability of human umbilical vein endothelial cells(HUVECs),indicating its potential therapeutic effects on tumor angiogenesis.Collectively,these results indicate that ELRL-MAP30 has significant tumor-targeting properties in MDA-MB-231 cancer cells and reveals potential therapeutic effects on angiogenesis.These findings indicate the potential role of ELRL-MAP30 in the targeted treatment of the TNBC cell line MDA-MB-231.展开更多
文摘猪繁殖与呼吸综合征(porcine reproductive and respiratory syndrome,PRRS)是世界上主要的猪传染性疾病之一,目前,疫苗和抗病毒药物只能提供有限的保护。本研究选择猪繁殖与呼吸综合征病毒(porcine reproductive and respiratory syndrome virus,PRRSV)JXA1-R株ORF1a、ORF3、ORF4、ORF5、ORF6、ORF7的保守区域为靶序列,利用pSilencer2.1-U6neo构建shRNA表达载体并转染Marc-145细胞。经实时荧光定量PCR、细胞病变及病毒滴度分析,结果显示,ORF1a-4-shRNA、ORF3-1-shRNA、ORF6-2-shRNA干扰质粒能明显抑制病毒基因的转录,并有效抑制PRRSV在Marc-145上的增殖,显著降低病毒滴度。最后筛选ORF6-2-shRNA表达质粒转染猪胎儿成纤维细胞,构建稳定转染细胞株,为抗PRRSV转基因猪的生产奠定了基础。
文摘Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ability,the arginine-glycine-aspartic(RGD)peptide and the epidermal growth factor receptor interference(EGFRi)peptide were fused with MAP30,which was named ELRL-MAP30.The efficiency of targeted therapy for triple-negative breast cancer(TNBC)MDA-MB-231 cells,which lack the expression of estrogen receptor(ER),Progesterone receptor(PgR)and human epidermal growth factor receptor-2(HER2),is limited.In this study,we focus on exploring the effect and mechanism of ELRL-MAP30 on TNBC MDA-MB-231 cells.First,we discovered that ELRL-MAP30 significantly inhibited the migration and invasion of MDA-MB-231 cells and induced MDA-MB-231 cell apoptosis.Moreover,ELRL-MAP30 treatment resulted in a significant increase in Bax expression and a decrease in Bcl-2 expression.Furthermore,ELRL-MAP30 triggered apoptosis via the Fak/EGFR/Erk and Ilk/Akt signaling pathways.In addition,recombinant ELRL-MAP30 can inhibit chicken embryonic angiogenesis,and also inhibit the tube formation ability of human umbilical vein endothelial cells(HUVECs),indicating its potential therapeutic effects on tumor angiogenesis.Collectively,these results indicate that ELRL-MAP30 has significant tumor-targeting properties in MDA-MB-231 cancer cells and reveals potential therapeutic effects on angiogenesis.These findings indicate the potential role of ELRL-MAP30 in the targeted treatment of the TNBC cell line MDA-MB-231.
